BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $212.67 million. The enterprise value is $141.81 million.
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, before market open.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 36.90 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 36.90M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +43.02% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 24.17M |
Valuation Ratios
The trailing PE ratio is 54.29 and the forward PE ratio is 38.92.
PE Ratio | 54.29 |
Forward PE | 38.92 |
PS Ratio | 4.89 |
Forward PS | 1.07 |
PB Ratio | 3.34 |
P/TBV Ratio | 3.34 |
P/FCF Ratio | 26.53 |
P/OCF Ratio | 17.53 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 43.78, with an EV/FCF ratio of 17.69.
EV / Earnings | 36.20 |
EV / Sales | 3.26 |
EV / EBITDA | 43.78 |
EV / EBIT | 75.67 |
EV / FCF | 17.69 |
Financial Position
The company has a current ratio of 5.03, with a Debt / Equity ratio of 0.09.
Current Ratio | 5.03 |
Quick Ratio | 4.66 |
Debt / Equity | 0.09 |
Debt / EBITDA | 1.50 |
Debt / FCF | 0.69 |
Interest Coverage | 1.33 |
Financial Efficiency
Return on equity (ROE) is 7.41% and return on invested capital (ROIC) is 2.10%.
Return on Equity (ROE) | 7.41% |
Return on Assets (ROA) | 1.42% |
Return on Invested Capital (ROIC) | 2.10% |
Return on Capital Employed (ROCE) | 2.25% |
Revenue Per Employee | $362,142 |
Profits Per Employee | $32,642 |
Employee Count | 120 |
Asset Turnover | 0.53 |
Inventory Turnover | 2.60 |
Taxes
In the past 12 months, BrainsWay has paid $523,000 in taxes.
Income Tax | 523,000 |
Effective Tax Rate | 11.78% |
Stock Price Statistics
The stock price has increased by +112.20% in the last 52 weeks. The beta is 0.25, so BrainsWay's price volatility has been lower than the market average.
Beta (5Y) | 0.25 |
52-Week Price Change | +112.20% |
50-Day Moving Average | 10.12 |
200-Day Moving Average | 9.79 |
Relative Strength Index (RSI) | 76.97 |
Average Volume (20 Days) | 50,925 |
Short Selling Information
Short Interest | 125,344 |
Short Previous Month | 103,174 |
Short % of Shares Out | 1.07% |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.95 |
Income Statement
In the last 12 months, BrainsWay had revenue of $43.46 million and earned $3.92 million in profits. Earnings per share was $0.08.
Revenue | 43.46M |
Gross Profit | 32.38M |
Operating Income | 1.87M |
Pretax Income | 778,000 |
Net Income | 3.92M |
EBITDA | 3.24M |
EBIT | 1.87M |
Earnings Per Share (EPS) | $0.08 |
Full Income Statement Balance Sheet
The company has $71.60 million in cash and $5.57 million in debt, giving a net cash position of $66.04 million or $1.79 per share.
Cash & Cash Equivalents | 71.60M |
Total Debt | 5.57M |
Net Cash | 66.04M |
Net Cash Per Share | $1.79 |
Equity (Book Value) | 63.75M |
Book Value Per Share | 1.73 |
Working Capital | 67.81M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $12.13 million and capital expenditures -$4.11 million, giving a free cash flow of $8.02 million.
Operating Cash Flow | 12.13M |
Capital Expenditures | -4.11M |
Free Cash Flow | 8.02M |
FCF Per Share | $0.22 |
Full Cash Flow Statement Margins
Gross margin is 74.51%, with operating and profit margins of 4.31% and 9.01%.
Gross Margin | 74.51% |
Operating Margin | 4.31% |
Pretax Margin | 10.22% |
Profit Margin | 9.01% |
EBITDA Margin | 7.45% |
EBIT Margin | 4.31% |
FCF Margin | 18.45% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 1.84% |
FCF Yield | 3.77% |
Analyst Forecast
The average price target for BrainsWay is $14.25, which is 7.79% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $14.25 |
Price Target Difference | 7.79% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BrainsWay has an Altman Z-Score of 2.37 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.37 |
Piotroski F-Score | 6 |